CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported a...
Things are about to get very exciting for investors in Moderna Inc (NASDAQ:MRNA). A clinical trial evaluating a vaccine designed to protect against...